qPharmetra provides pharmacometric analysis, clinical pharmacology consulting and custom software tools to help drug companies develop better medicines.
Newsflash
- Find the latest news on our LinkedIn Page!
-
Introducing three new colleagues!
Introducing three new colleagues!
-
New Publications
New Publications
Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N-dimethyltryptamine benzoate) in healthy participants
https://www.linkedin.com/feed/update/urn:li:activity:7200888698358431744A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders
https://www.linkedin.com/feed/update/urn:li:activity:7184520052254085120A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populations
https://www.linkedin.com/feed/update/urn:li:activity:7183377271368392704 -
Pharmacometrics Network Benelux meeting in Leuven
Pharmacometrics Network Benelux meeting in Leuven



